Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
Identification and characterization of a fibroblast marker: FSP1
Experiments in which the in vitro overexpression of FSP1 cDNA in tubular epithelium is accompanied by conversion to a mesenchymal phenotype are observed, as characterized by a more stellate and elongated fibroblast- like appearance, a reduction in cytokeratin, and new expression of vimentin.
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.
- J. Karhausen, G. Furuta, J. Tomaszewski, R. Johnson, S. Colgan, V. Haase
- BiologyJournal of Clinical Investigation
- 15 October 2004
These studies provide insight into tissue microenvironmental changes during model inflammatory bowel disease and identify HIF-1 as a critical factor for barrier protection during mucosal insult.
Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer
Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high- risk patients treated with RP or RT did better then those treated by implant.
Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR
Ren renal neoplasms with the t(6;11) are a distinctive neoplastic entity with many similarities to the Xp11 translocation carcinomas, and together with the latter form a growing “MiTF/TFE family” of translocations carcinomas.
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
PURPOSE To present nomograms providing estimates of prostate-specific antigen (PSA) failure-free survival after radical prostatectomy (RP) or external-beam radiation therapy (RT) for men diagnosed…
Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
- K. Brukamp, A. Doyle, R. Bloom, N. Bunin, J. Tomaszewski, B. Čižman
- Medicine, BiologyAmerican Society of Nephrology. Clinical Journal
- 1 July 2006
Review of the literature reveals a close temporal relationship between the development of nephrotic syndrome shortly after cessation of immunosuppression and the diagnosis of chronic graft-versus-host disease (GVHD).
REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1
Reduction in immunosuppression is an effective initial therapy for Posttransplant lymphoproliferative disorder and clinical prognostic factors may allow clinicians to identify which patients are likely to respond to reduction in immuno- suppression.
Diabetic mastopathy: a distinctive clinicopathologic entity.
Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
The first mouse model of VHL-associated renal disease is presented that will provide a basis for further genetic studies to define the molecular events that are required for the progression of VVHL- associated renal cysts to clear cell renal cell carcinoma.